Aromatic compounds and pharmaceutical uses thereof

A pharmaceutical composition comprising a compound of formula (I)

• wherein
• R1 is a C1-C4 alkyl group, a C1-C4 hydroxyalkyl group, or a C1-C4 haloalkyl group;
• R2 is a C6-C9 alkyl group, a C4-C9 hydroxyalkyl group, a C4-C9 haloalkyl group, a heteroalkyl group having 4-9 atoms of which 1-3 atoms are heteroatoms, a C4-C9 alkenyl group having 1-2 double bonds, a heteroalkenyl group having 1-2 double bonds and 5-9 atoms of which 1-2 atoms are heteroatoms, an —O—(C3-C8) alkyl group, an —O—(C3-C8) hydroxyalkyl group, an —O—(C3-C8) haloalkyl group, an —O—(C3-C8) alkenyl group having 1-2 double bonds, an-O—(C3-C8) haloalkyl group, an O-heteroalkenyl group having 5-8 atoms of which 1 is heteroatom and 1 double bond, an —O—(C3-C8) haloalkenyl group having 1-2 double bonds, a C4-C9 alkynyl group having 1-2 triple bonds, an —O—(C3-C8) alkynyl group having 1-2 triple bonds, an amine group having a hydrogen atom and a C3-C8 alkyl group, an amine group having a hydrogen atom and a (C1-C6) ketone group, or an amine group having a C1-C9 alkyl group and a C3-C8 alkyl group;
• R3, R4, and R5 are each a hydrogen atom or a halogen atom,
• R6 and R7 are the same or different and are independently chosen from a hydrogen atom and an C1-C6 alkyl group, or R6 and R7 together can form a cycloalkyl group;
• X is a hydroxymethyl, a carboxylic acid, a carboxylic ester, a glyceride, an anhydride, a carboxamide, or a phospholipid, or a prodrug thereof;
• n is 0, 1, or 2;
• or a pharmaceutically acceptable salt, solvate, solvate of such salt, or prodrug thereof;
• wherein when X is a carboxamide, the carboxamide is chosen from C(O)NH2, N-methyl carboxamide, N,N-dimethyl carboxamide, N-ethyl carboxamide and N,N-diethyl carboxamide;
• wherein the composition is formulated for oral administration;
• and
• wherein the composition is in the form of a gelatin capsule, a tablet, or a sachet.